Quantcast

Latest Lamotrigine Stories

2009-01-05 08:00:00

However, AED Brands Facing Generic Competition Will be Dropped or Pushed to Tier Three of Many MCO Formularies, According to a New Report from Decision Resources WALTHAM, Mass., Jan. 5 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the willingness of neurologists to prescribe generic anti-epileptic drugs (AEDs) varies dramatically by indication, affording branded AEDs protection in the epilepsy...

cf5433d33f12a6421789d7ec9ae20c6c1
2008-12-17 08:35:00

The drugs that cure epileptic seizures are known to increase the risk of suicide, and federal regulators decided Tuesday drug companies must clearly display that warning.The Food and Drug Administration made the announcement a year after the agency first said patients taking the drugs have a slightly higher risk for suicide than those taking dummy pills.One in 500 patients face an increased risk of suicidal thoughts and behavior while taking the drugs. The new warning emphasizes that risks...

2008-12-16 14:56:47

The U.S. Food and Drug Administration says it will require suicide warnings on all anti-epileptic drugs, including those used to treat other conditions. The federal agency says the warning about the risk of suicidal thoughts and suicidality will be required on all anti-epileptic drugs that are also used to treat psychiatric disorders, migraine headaches and other conditions. The warnings will appear on all prescribing information or labeling. Patients being treated with anti-epileptic drugs...

2008-12-08 13:12:00

ATLANTA, Dec. 8 /PRNewswire/ -- UCB today announced new findings from analyses of pooled Vimpat(R) (lacosamide) clinical trial data, demonstrating that the new antiepileptic drug (AED) starts working during the first week of treatment and across doses in a challenging patient population, when administered as adjunctive therapy. The analyses also showed that Vimpat(R) provides consistent seizure reduction versus placebo, when added to concomitant AEDs, and that it is generally...

2008-12-03 07:00:00

WALTHAM, Mass., Dec. 3 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the modest introduction of emerging therapies in the bipolar depression market will not compensate for extensive generic erosion of branded agents, resulting in a decrease of just over $1 billion in drug sales through 2017 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan. The new...

2008-12-05 08:54:35

The cause of autism remains a mystery to the medical community, but researchers have found a link between an epilepsy drug and an increased risk of a child developing autism.A new study shows women who take the epilepsy drug valproate while pregnant may significantly increase their unborn baby's risk of developing autism.In an ongoing study conducted by the Liverpool and Manchester Neurodevelopment Group, researchers are examining 632 children, about half of whom were exposed to epilepsy...

2008-12-03 19:49:06

Prenatal exposure to the epilepsy drug valproate may increase a child's risk of autism, a British researcher says. Lead author Gus Baker of the University of Liverpool said the preliminary results are based on an ongoing study involving 632 children, nearly half of whom were exposed during gestation to epilepsy drugs such as valproate, lamotrigine and carbamazepine. The study, published in the journal Neurology, found mothers who were given valproate during pregnancy were seven times more...

2008-11-12 12:00:15

GlaxoSmithKline has announced that it will close its manufacturing site in Dartford. Following the conclusion of a recent review of activities at its manufacturing site in Dartford, the company proposes to close the facility and transfer production to alternative facilities. The proposed closure, which is subject to consultation with trade union and staff representatives, would result in the loss of around 620 established roles at the Dartford site over the next four years, with closure of...

2008-08-11 12:01:13

WALTHAM, Mass., Aug. 11 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that an astonishing 52.3 percent of newly diagnosed bipolar disorder patients are prescribed antidepressant drugs first line. The new report entitled Treatment Algorithms in Bipolar Disorder finds that this high preponderance of early-line antidepressant use stems from primary care physician prescribing. Surveyed primary...

2008-08-01 12:01:08

Lupin Pharmaceuticals has received final approval for its abbreviated new drug application for divalproex sodium delayed-release tablets, 125mg, 250mg and 500mg from the FDA. Commercial shipments of the product have already commenced. Lupin's divalproex sodium delayed-release tablets are the AB-rated generic equivalent of Abbott Laboratories's Depakote tablets, indicated for the treatment of certain types of seizures and convulsions. It may be prescribed alone or with other epilepsy...


Word of the Day
omphalos
  • The navel or umbilicus.
  • In Greek archaeology: A central boss, as on a shield, a bowl, etc.
  • A sacred stone in the temple of Apollo at Delphi, believed by the Greeks to mark the 'navel' or exact center-point of the earth.
'Omphalos' comes from the ancient Greek.
Related